investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
MicroRNA Function in the Immune System
David Baltimore
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
David Baltimore
California Institute of Technology
Pasadena, United States
Related projects
Katerina V Gurova
Modulation of cancer specific transcriptional factors with small molecules
Leukaemia
Michael L Cleary
Role of PGDH in leukemia pathogenesis
Leukaemia
Effie W Petersdorf
Clinical Significance of MHC Haplotypes in HCT
Leukaemia
Genoveffa Franchini
T-Cell Transformation by Oncoviruses
Leukaemia
Pathology
Hematology and hematologic malignancies
Ronen Marmorstein
Structure and Function of Protein Acetyltransferases
Leukaemia
Catherine Ju-Ying Wu
Defining the Impact of Clonal Evolution on Chronic Lymphocytic Leukemia
Leukaemia
Pathology
Hematology and hematologic malignancies
Neil Osheroff
Function and Biology of Eukaryotic DNA Topoisomerases
Leukaemia
Ann Mullally
Functional and Molecular Dissection of Myeloproliferative Neoplasm Stem Cells
Leukaemia
Clark W Distelhorst
Targeting PKM2-InsP3R interaction to treat AML
Leukaemia
Hematology and hematologic malignancies